Диссертация (1145852), страница 15
Текст из файла (страница 15)
Quercetin enhances ABCA1 expressionand cholesterol efflux through a p38-dependent pathway in macrophages // J Lipid Res.2012. Т. 53. № 9. — C. 1840-50.40. Chawla A., Boisvert W.A., Lee C.H., Laffitte B.A., Barak Y., Joseph S.B.,Liao D., Nagy L., Edwards P.A., Curtiss L.K., Evans R.M., Tontonoz P. A PPAR gammaLXR-ABCA1 pathway in macrophages is involved in cholesterol efflux andatherogenesis // Mol Cell. 2001. Т.
7. № 1. — C. 161-71.41. Chen F., Eriksson P., Hansson G.K., Herzfeld I., Klein M., Hansson L.O.,Valen G. Expression of matrix metalloproteinase 9 and its regulators in the unstablecoronary atherosclerotic plaque // Int J Mol Med. 2005. Т. 15. № 1. — C. 57-65.42. Chen S.G., Xiao J., Liu X.H., Liu M.M., Mo Z.C., Yin K., Zhao G.J., JiangJ., Cui L.B., Tan C.Z., Yin W.D., Tang C.K. Ibrolipim increases ABCA1/G1 expressionby the LXRalpha signaling pathway in THP-1 macrophage-derived foam cells // ActaPharmacol Sin.
2010. Т. 31. № 10. — C. 1343-9.43. Chen W., Silver D.L., Smith J.D., Tall A.R. Scavenger receptor-BI inhibitsATP-binding cassette transporter 1- mediated cholesterol efflux in macrophages // J BiolChem. 2000. Т. 275. № 40. — C. 30794-800.44. Chen X., Zhao Y., Guo Z., Zhou L., Okoro E.U., Yang H. Transcriptionalregulation of ATP-binding cassette transporter A1 expression by a novel signalingpathway // J Biol Chem. 2011. Т. 286. № 11. — C. 8917-23.9945. Chen Z., Ishibashi S., Perrey S., Osuga J., Gotoda T., Kitamine T., TamuraY., Okazaki H., Yahagi N., Iizuka Y., Shionoiri F., Ohashi K., Harada K., Shimano H.,Nagai R., Yamada N. Troglitazone inhibits atherosclerosis in apolipoprotein E-knockoutmice: pleiotropic effects on CD36 expression and HDL // Arterioscler Thromb Vasc Biol.2001.
Т. 21. № 3. — C. 372-7.46. Chinetti-Gbaguidi G., Staels B. Lipid ligand-activated transcription factorsregulating lipid storage and release in human macrophages // Biochim Biophys Acta.2009. Т. 1791. № 6. — C. 486-93.47. Choi H.Y., Rahmani M., Wong B.W., Allahverdian S., McManus B.M.,Pickering J.G., Chan T., Francis G.A. ATP-binding cassette transporter A1 expressionand apolipoprotein A-I binding are impaired in intima-type arterial smooth muscle cells// Circulation. 2009. Т. 119. № 25.
— C. 3223-31.48. Clee S.M., Kastelein J.J., van Dam M., Marcil M., Roomp K., Zwarts K.Y.,Collins J.A., Roelants R., Tamasawa N., Stulc T., Suda T., Ceska R., Boucher B.,Rondeau C., DeSouich C., Brooks-Wilson A., Molhuizen H.O., Frohlich J., Genest J., Jr.,Hayden M.R. Age and residual cholesterol efflux affect HDL cholesterol levels andcoronary artery disease in ABCA1 heterozygotes // J Clin Invest.
2000. Т. 106. № 10. —C. 1263-70.49. Clinton S.K., Underwood R., Hayes L., Sherman M.L., Kufe D.W., Libby P.Macrophage colony-stimulating factor gene expression in vascular cells and inexperimental and human atherosclerosis // Am J Pathol. 1992. Т. 140. № 2. — C. 30116.50. Costet P., Luo Y., Wang N., Tall A.R. Sterol-dependent transactivation ofthe ABC1 promoter by the liver X receptor/retinoid X receptor // J Biol Chem. 2000. Т.275. № 36. — C.
28240-5.51. De Villiers W.J., Smith J.D., Miyata M., Dansky H.M., Darley E., GordonS. Macrophage phenotype in mice deficient in both macrophage-colony-stimulatingfactor (op) and apolipoprotein E // Arterioscler Thromb Vasc Biol. 1998. Т. 18. № 4. —C. 631-40.10052. Dean M., Rzhetsky A., Allikmets R. The human ATP-binding cassette(ABC) transporter superfamily // Genome Res. 2001. Т. 11. № 7. — C. 1156-66.53. Denis M., Bissonnette R., Haidar B., Krimbou L., Bouvier M., Genest J.Expression, regulation, and activity of ABCA1 in human cell lines // Mol Genet Metab.2003.
Т. 78. № 4. — C. 265-74.54. Di Gregoli K., Johnson J.L. Role of colony-stimulating factors inatherosclerosis // Curr Opin Lipidol. 2012. Т. 23. № 5. — C. 412-21.55. Eldrup N., Gronholdt M.L., Sillesen H., Nordestgaard B.G. Elevated matrixmetalloproteinase-9 associated with stroke or cardiovascular death in patients with carotidstenosis // Circulation. 2006. Т. 114. № 17. — C. 1847-54.56.
Feig J.E., Feig J.L. Macrophages, dendritic cells, and regression ofatherosclerosis // Front Physiol. 2012. Т. 3. — C. 286.57. Feig J.E., Shamir R., Fisher E.A. Atheroprotective effects of HDL: beyondreverse cholesterol transport // Curr Drug Targets. 2008.
Т. 9. № 3. — C. 196-203.58. Feige J.N., Gelman L., Michalik L., Desvergne B., Wahli W. Frommolecular action to physiological outputs: peroxisome proliferator-activated receptors arenuclear receptors at the crossroads of key cellular functions // Prog Lipid Res. 2006. Т.45. № 2. — C. 120-59.59. Feng B., Tabas I. ABCA1-mediated cholesterol efflux is defective in freecholesterol-loaded macrophages.
Mechanism involves enhanced ABCA1 degradation ina process requiring full NPC1 activity // J Biol Chem. 2002. Т. 277. № 45. — C. 4327180.60. Ferroni P., Basili S., Martini F., Cardarello C.M., Ceci F., Di Franco M.,Bertazzoni G., Gazzaniga P.P., Alessandri C. Serum metalloproteinase 9 levels in patientswith coronary artery disease: a novel marker of inflammation // J Investig Med.
2003. Т.51. № 5. — C. 295-300.61. Francone O.L., Royer L., Boucher G., Haghpassand M., Freeman A., BreesD., Aiello R.J. Increased cholesterol deposition, expression of scavenger receptors, andresponse to chemotactic factors in Abca1-deficient macrophages // Arterioscler ThrombVasc Biol. 2005. Т. 25. № 6. — C. 1198-205.10162. Frikke-Schmidt R., Nordestgaard B.G., Schnohr P., Steffensen R., TybjaergHansen A.
Mutation in ABCA1 predicted risk of ischemic heart disease in theCopenhagen City Heart Study Population // J Am Coll Cardiol. 2005. Т. 46. № 8. — C.1516-20.63. Frikke-Schmidt R., Nordestgaard B.G., Jensen G.B., Steffensen R.,Tybjaerg-Hansen A. Genetic variation in ABCA1 predicts ischemic heart disease in thegeneral population // Arterioscler Thromb Vasc Biol. 2008. Т. 28. № 1. — C.
180-6.64. Galis Z.S., Khatri J.J. Matrix metalloproteinases in vascular remodeling andatherogenesis: the good, the bad, and the ugly // Circ Res. 2002. Т. 90. № 3. — C. 25162.65. Galis Z.S., Sukhova G.K., Lark M.W., Libby P. Increased expression ofmatrix metalloproteinases and matrix degrading activity in vulnerable regions of humanatherosclerotic plaques // J Clin Invest. 1994. Т.
94. № 6. — C. 2493-503.66. Genvigir F.D., Rodrigues A.C., Cerda A., Arazi S.S., Willrich M.A., OliveiraR., Hirata M.H., Dorea E.L., Bernik M.M., Curi R., Hirata R.D. Effects of lipid-loweringdrugs on reverse cholesterol transport gene expressions in peripheral blood mononuclearand HepG2 cells // Pharmacogenomics. 2010. Т. 11. № 9. — C. 1235-46.67.
Giaginis C., Klonaris C., Katsargyris A., Kouraklis G., Spiliopoulou C.,Theocharis S. Correlation of Peroxisome Proliferator-Activated Receptor-gamma(PPAR-gamma) and Retinoid X Receptor-alpha (RXR-alpha) expression with clinicalrisk factors in patients with advanced carotid atherosclerosis // Med Sci Monit. 2011. Т.17. № 7. — C. CR381-91.68. Glomset J.A.
The plasma lecithins:cholesterol acyltransferase reaction // JLipid Res. 1968. Т. 9. № 2. — C. 155-67.69. Gordon D.J., Probstfield J.L., Garrison R.J., Neaton J.D., Castelli W.P.,Knoke J.D., Jacobs D.R., Jr., Bangdiwala S., Tyroler H.A. High-density lipoproteincholesterol and cardiovascular disease. Four prospective American studies // Circulation.1989. Т. 79. № 1. — C.
8-15.10270. Gough P.J., Gomez I.G., Wille P.T., Raines E.W. Macrophage expression ofactive MMP-9 induces acute plaque disruption in apoE-deficient mice // J Clin Invest.2006. Т. 116. № 1. — C. 59-69.71. Guay S.P., Brisson D., Munger J., Lamarche B., Gaudet D., Bouchard L.ABCA1 gene promoter DNA methylation is associated with HDL particle profile andcoronary artery disease in familial hypercholesterolemia // Epigenetics. 2012. Т. 7.
№ 5.— C. 464-72.72. Gygi S.P., Rochon Y., Franza B.R., Aebersold R. Correlation betweenprotein and mRNA abundance in yeast // Mol Cell Biol. 1999. Т. 19. № 3. — C. 172030.73. Hagemann C., Anacker J., Ernestus R.I., Vince G.H. A complete compilationof matrix metalloproteinase expression in human malignant gliomas // World J ClinOncol. 2012. Т. 3. № 5. — C. 67-79.74. Holland I Barry, Susan P. C. Cole, Karl Kuchler, Christopher F. HigginsABC Proteins: From Bacteria to Man // Academic Press.
2003. — С.530.75. Holven K.B., Retterstol K., Ueland T., Ulven S.M., Nenseter M.S., SandvikM., Narverud I., Berge K.E., Ose L., Aukrust P., Halvorsen B. Subjects with low plasmaHDL cholesterol levels are characterized by an inflammatory and oxidative phenotype //PLoS One. 2013. Т. 8. № 11. — C. e78241.76. Hsieh V., Kim M.J., Gelissen I.C., Brown A.J., Sandoval C., Hallab J.C.,Kockx M., Traini M., Jessup W., Kritharides L. Cellular Cholesterol RegulatesUbiquitination and Degradation of the Cholesterol Export Proteins ABCA1 and ABCG1// J Biol Chem. 2014. Т.
289. № 11. — C. 7524-36.77. Hsueh W.A., Bruemmer D. Peroxisome proliferator-activated receptorgamma: implications for cardiovascular disease // Hypertension. 2004. Т. 43. № 2. — C.297-305.78. Ikeda U., Shimada K. Matrix metalloproteinases and coronary arterydiseases // Clin Cardiol. 2003. Т. 26. № 2.
— C. 55-9.79. Inokubo Y., Hanada H., Ishizaka H., Fukushi T., Kamada T., Okumura K.Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1103are increased in the coronary circulation in patients with acute coronary syndrome // AmHeart J. 2001. Т. 141. № 2. — C.
211-7.80. Jensen M.K., Pai J.K., Mukamal K.J., Overvad K., Rimm E.B. Commongenetic variation in the ATP-binding cassette transporter A1, plasma lipids, and risk ofcoronary heart disease // Atherosclerosis. 2007. Т. 195. № 1. — C. e172-80.81.Kakko S., Kelloniemi J., von Rohr P., Hoeschele I., Tamminen M.,Brousseau M.E., Kesaniemi Y.A., Savolainen M.J. ATP-binding cassette transporter A1locus is not a major determinant of HDL-C levels in a population at high risk for coronaryheart disease // Atherosclerosis. 2003.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
